newsfilter
← Latest News
ACCESS Newswire·

Biophytis Has Filed with The FDA For Authorization to Initiate SARA-31 Phase 3 Study in Sarcopenia

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / July 10, 2023 / Biophytis SA , a clinical-stage biotechnology company specializing in the